← Back to Search

Behavioural Intervention

The Donor App for Kidney Failure

N/A

Recruiting

Led By Andrew Cameron, MD PhD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 18 years of age

On the kidney-only or liver-only transplant waiting list at a collaborating center

Must not have

Younger than 18 years of age

Not on the kidney or liver transplant waiting list

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial uses a web app to help transplant patients on a waitlist communicate their need for a living donor, and provides potential donors the opportunity to engage with the evaluation process.

Who is the study for?

This trial is for adults over 18 who are on the waiting list for a kidney or liver transplant at a participating center. It's not open to those under 18, not on the transplant waitlist, or waiting for multiple organ transplants.

What is being tested?

The study is testing 'The Donor App', which is designed to help patients in need of an organ transplant use social media to find living donors and allows potential donors to start the evaluation process.

What are the potential side effects?

Since this trial involves using a web-based application rather than medical treatment, there are no direct physical side effects associated with traditional clinical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am on the waiting list for a kidney or liver transplant at a participating center.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am under 18 years old.

Select...

I am not waiting for a kidney or liver transplant.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Live donor transplantation

Potential donors identified

Secondary study objectives

App utilization as assessed by number of participants with story completion and posting in the donor app

The Donor App Implementation

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: The Donor AppExperimental Treatment1 Intervention

Select physicians and research staff from about 15 transplant hospitals will be given access to distribute the application to patients who the above people feel could benefit from the application. After obtaining informed consent, an approved member of the study team will enter the participant's name, contact info, and organ needed into the Donor App's secure management portal to send an email or text message with a unique and protected invitation link to the participant. Using this link the participant will be allowed to use the Donor App indefinitely.

0 / 4Eligibility criteria met